Gainers
- Rail Vision Ltd. (NASDAQ:RVSN) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday.
- Brickell Biotech, Inc. (NASDAQ:BBI) rose 29% to $0.2999 in pre-market trading after the company announced the sale of sofpironium bromide to Botanix Pharmaceuticals for $9 million in upfront and potential near-term regulatory milestone payments. The company is also eligible to receive additional success-based regulatory and sales milestone payments of up to $168 million.
- Aclarion, Inc. (NASDAQ:ACON) rose 28.5% to $2.21 in pre-market trading after declining over 5% on Tuesday. The company had its IPO on April 22.
- Livent Corporation (NYSE:LTHM) rose 23.1% to $26.98 in pre-market trading after the company reported better-than-expected Q1 results and raised FY22 guidance.
- Sharps Technology, Inc. (NASDAQ:STSS) rose 20.3% to $1.54 in pre-market trading after climbing around 6% on Tuesday.
- United States Antimony Corporation (NASDAQ:UAMY) rose 16.5% to $0.48 in pre-market trading.
- CASI Pharmaceuticals, Inc. (NASDAQ:CASI) rose 15% to $0.49 in pre-market trading.
- Senmiao Technology Limited (NASDAQ:AIHS) rose 12.3% to $1.27 in pre-market trading.
- Amesite Inc. (NASDAQ:AMST) shares rose 10.7% to $0.7096 in pre-market trading after declining over 6% on Tuesday.
- Alaunos Therapeutics, Inc. (NASDAQ:TCRT) rose 9.9% to $0.61 in pre-market trading after jumping around 13% on Tuesday.
- Expion360 Inc. (NASDAQ:XPON) rose 9.7% to $3.96 in pre-market trading. Expion360 secured $300,000 line of credit from GM Financial to support expansion of national sales and distribution channels.
- CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) rose 8.6% to $0.38 in pre-market trading.
- The Scotts Miracle-Gro Company (NYSE:SMG) rose 7.6% to $114.00 in pre-market trading. Scotts Miracle-Gro announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.
- Starbucks Corporation (NASDAQ:SBUX) rose 6.4% to $79.10 in pre-market trading as the company reported second-quarter revenue of $7.64 billion, which was up 15% year-over-year. The quarterly revenue was a second-quarter record for the company and came in ahead of a consensus estimate of $7.6 billion.
- Advanced Micro Devices, Inc. (NASDAQ:AMD) shares rose 6% to $96.60 in pre-market trading after the company reported better-than-expected Q1 adjusted EPS and sales results and raised FY22 sales guidance.
Don’t forget to check out our premarket coverage here .
Losers
- Lyft, Inc (NASDAQ:LYFT) shares fell 27.2% to $22.40 in pre-market trading. Lyft reported a narrower loss for its first quarter, while sales topped estimates. However, the company issued a weak outlook for the second quarter.
- Herbalife Nutrition Ltd. (NYSE:HLF) shares fell 15.6% to $23.25 in pre-market trading after the company reported a decline in Q1 EPS results.
- Akamai Technologies, Inc. (NASDAQ:AKAM) fell 13.9% to $98.02 in pre-market trading after the company reported worse-than-expected Q1 results.
- Blue Water Vaccines, Inc. (NASDAQ:BWV) fell 13.5% to $5.58 in pre-market trading. Blue Water Vaccines S-1 showed registration for 2.4 million share common stock offering via selling shareholders.
- IonQ, Inc. (NYSE:IONQ) shares fell 13.5% to $6.18 in pre-market trading. IonQ shares dropped 9% on Tuesday following a short report by Scorpion Capital.
- XORTX Therapeutics Inc. (NASDAQ:XRTX) fell 10.9% to $1.63 in pre-market trading. XORTX Therapeutics shares jumped 59% on Tuesday after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.
- Revolve Group, Inc. (NYSE:RVLV) fell 9.9% to $39.20 in pre-market trading after the company reported Q1 earnings results.
- Swvl Holdings Corp. (NASDAQ:SWVL) fell 8.5% to $6.62 in pre-market trading after dipping 17% on Tuesday.
- Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) shares fell 8.3% to $3.21 in pre-market trading. Sonoma Pharmaceuticals shares jumped around 32% on Tuesday after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant.
- Redbox Entertainment Inc. (NASDAQ:RDBX) fell 7.6% to $6.12 in pre-market trading after dipping 22% on Tuesday.
- Ouster, Inc. (NYSE:OUST) fell 6.3% to $3.25 in pre-market trading after the company reported worse-than-expected Q1 results.
- Match Group, Inc. (NASDAQ:MTCH) fell 6.3% to $74.05 in pre-market trading after the company reported Q1 earnings results and issued Q2 sales guidance below analyst estimates.
